Genetic obesity syndromes

Frontiers of Hormone Research

Volumn 36, Issue , 2007, Pages 37-60

  Goldstone, A ^a,c   Beales, P ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALMS1 PROTEIN, HUMAN; PROTEIN; VESICULAR TRANSPORT PROTEIN; VPS13B PROTEIN, HUMAN;

ACROCEPHALOSYNDACTYLY; ALBRIGHT SYNDROME; ANIMAL; BARDET BIEDL SYNDROME; BRAIN; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 2; CHROMOSOME 6; CHROMOSOME 9; CONGENITAL MALFORMATION; FEEDING BEHAVIOR; FRAGILE X SYNDROME; GENE DELETION; GENETICS; HUMAN; OBESITY; PRADER WILLI SYNDROME; REVIEW; RUBINSTEIN SYNDROME; SYNDROME;

ACROCEPHALOSYNDACTYLIA; ANIMALS; BARDET-BIEDL SYNDROME; BRAIN; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 9; FEEDING BEHAVIOR; FIBROUS DYSPLASIA, POLYOSTOTIC; FRAGILE X SYNDROME; GENE DELETION; HUMANS; OBESITY; PRADER-WILLI SYNDROME; PROTEINS; RUBINSTEIN-TAYBI SYNDROME; SYNDROME; VESICULAR TRANSPORT PROTEINS;

EID: 43049131518     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000115336     Document Type: Review

References (143)

1. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA: New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet 1999;36:437-446.
2. Katsanis N, Beales PL, Woods MO, Lewis RA, Green JS, Parfrey PS, Ansley SJ, Davidson WS, Lupski JR: Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet 2000;26: 67-70.
3. Slavotinek AM, Stone EM, Mykytyn K, Heckenlively JR, Green JS, Heon E, Musarella MA, Parfrey PS, Sheffield VC, Biesecker LG: Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet 2000;26: 15-16.
4. Stoetzel C, Laurier V, Davis EE, Muller J, Rix S, Badano JL, Leitch CC, Salem N, Chouery E, Corbani S, Jalk N, Vicaire S, Sarda P, Hamel C, Lacombe D, Holder M, Odent S, Holder S, Brooks AS, Elcioglu NH, Da Silva E, Rossillion B, Sigaudy S, de Ravel TJ, Alan Lewis R, Leheup B, Verloes A, Amati-Bonneau P, Megarbane A, Poch O, Bonneau D, Beales PL, Mandel JL, Katsanis N, Dollfus H: BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet 2006;38:521-524.
5. Chiang AP, Beck JS, Yen HJ, Tayeh MK, Scheetz TE, Swiderski RE, Nishimura DY, Braun TA, Kim KY, Huang J, Elbedour K, Carmi R, Slusarski DC, Casavant TL, Stone EM, Sheffield VC: Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci USA 2006;103: 6287-6292.
6. Chiang AP, Nishimura D, Searby C, Elbedour K, Carmi R, Ferguson AL, Secrist J, Braun T, Casavant T, Stone EM, Sheffield VC: Comparative genomic analysis identifies an ADP-ribosylation factor-like gene as the cause of Bardet-Biedl syndrome (BBS3). Am J Hum Genet 2004;75:475-484.
7. Fan Y, Esmail MA, Ansley SJ, Blacque OE, Boroevich K, Ross AJ, Moore SJ, Badano JL, May-Simera H, Compton DS, Green JS, Lewis RA, van Haelst MM, Parfrey PS, Baillie DL, Beales PL, Katsanis N, Davidson WS, Leroux MR: Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat Genet 2004;36:989-993.
8. Li JB, Gerdes JM, Haycraft CJ, Fan Y, Teslovich TM, May-Simera H, Li H, Blacque OE, Li L, Leitch CC, Lewis RA, Green JS, Parfrey PS, Leroux MR, Davidson WS, Beales PL, Guay-Woodford LM, Yoder BK, Stormo GD, Katsanis N, Dutcher SK: Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 2004;117:541-552.
9. Kim JC, Badano JL, Sibold S, Esmail MA, Hill J, Hoskins BE, Leitch CC, Venner K, Ansley SJ, Ross AJ, Leroux MR, Katsanis N, Beales PL: The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression. Nat Genet 2004;36:462-470.
10. Kim JC, Ou YY, Badano JL, Esmail MA, Leitch CC, Fiedrich E, Beales PL, Archibald JM, Katsanis N, Rattner JB, Leroux MR: MKKS/BBS6, a divergent chaperonin-like protein linked to the obesity disorder Bardet-Biedl syndrome, is a novel centrosomal component required for cytokinesis. J Cell Sci 2005;118:1007-1020.
11. Ross AJ, May-Simera H, Eichers ER, Kai M, Hill J, Jagger DJ, Leitch CC, Chapple JP, Munro PM, Fisher S, Tan PL, Phillips HM, Leroux MR, Henderson DJ, Murdoch JN, Copp AJ, Eliot MM, Lupski JR, Kemp DT, Dollfus H, Tada M, Katsanis N, Forge A, Beales PL: Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat Genet 2005;37:1135-1140.
12. Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskins BE, Leitch CC, Kim JC, Ross AJ, Eichers ER, Teslovich TM, Mah AK, Johnsen RC, Cavender JC, Lewis RA, Leroux MR, Beales PL, Katsanis N: Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 2003;425:628-633.
13. Blacque OE, Reardon MJ, Li C, McCarthy J, Mahjoub MR, Ansley SJ, Badano JL, Mah AK, Beales PL, Davidson WS, Johnsen RC, Audeh M, Plasterk RH, Baillie DL, Katsanis N, Quarmby LM, Wicks SR, Leroux MR: Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev 2004;18:1630-1642.
14. Mykytyn K, Mullins RF, Andrews M, Chiang AP, Swiderski RE, Yang B, Braun T, Casavant T, Stone EM, Sheffield VC: Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly. Proc Natl Acad Sci USA 2004;101:8664-8669.
15. Kulaga HM, Leitch CC, Eichers ER, Badano JL, Lesemann A, Hoskins BE, Lupski JR, Beales PL, Reed RR, Katsanis N: Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat Genet 2004;36:994-998.
16. Fath MA, Mullins RF, Searby C, Nishimura DY, Wei J, Rahmouni K, Davis RE, Tayeh MK, Andrews M, Yang B, Sigmund CD, Stone EM, Sheffield VC: Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome. Hum Mol Genet 2005;14:1109-1118.
17. Nishimura DY, Fath M, Mullins RF, Searby C, Andrews M, Davis R, Andorf JL, Mykytyn K, Swiderski RE, Yang B, Carmi R, Stone EM, Sheffield VC: Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc Natl Acad Sci USA 2004;101:16588-16593.
18. Yen HJ, Tayeh MK, Mullins RF, Stone EM, Sheffield VC, Slusarski DC: Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffer's vesicle cilia function. Hum Mol Genet 2006;15:667-677.
19. Grace C, Beales P, Summerbell C, Jebb SA, Wright A, Parker D, Kopelman P: Energy metabolism in Bardet-Biedl syndrome. Int J Obes Relat Metab Disord 2003;27:1319-1324.
20. Eichers ER, Abd-El-Barr MM, Paylor R, Lewis RA, Bi W, Lin X, Meehan TP, Stockton DW, WU SM, Lindsay E, Justice MJ, Beales PL, Katsanis N, Lupski JR: Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. Hum Genet 2006.
21. Croft JB, Morrell D, Chase CL, Swift M: Obesity in heterozygous carriers of the gene for the Bardet-Biedl syndrome. Am J Med Genet 1995;55:12-15.
22. Croft JB, Swift M: Obesity, hypertension, and renal disease in relatives of Bardet-Biedl syndrome sibs. Am J Med Genet 1990;36:37-42.
23. Reed DR, Ding Y, Xu W, Cather C, Price RA: Human obesity does not segregate with the chromosomal regions of Prader-Willi, Bardet-Biedl, Cohen, Borjeson or Wilson-Turner syndromes. Int J Obes Relat Metab Disord 1995;19:599-603.
24. Andersen KL, Echwald SM, Larsen LH, Hamid YH, Glumer C, Jorgensen T, Borch-Johnsen K, Andersen T, Sorensen TI, Hansen T, Pedersen O: Variation of the McKusick-Kaufman gene and studies of relationships with common forms of obesity. J Clin Endocrinol Metab 2005;90:225-230.
25. Fan Y, Rahman P, Peddle L, Hefferton D, Gladney N, Moore SJ, Green JS, Parfrey PS, Davidson WS: Bardet-Biedl syndrome 1 genotype and obesity in the Newfoundland population. Int J Obes Relat Metab Disord 2004;28:680-684.
26. Benzinou M, Walley A, Lobbens S, Charles MA, Jouret B, Fumeron F, Balkau B, Meyre D, Froguel P: Bardet-Biedl syndrome gene variants are associated with both childhood and adult common obesity in French Caucasians. Diabetes 2006;55:2876-2882.
27. Russell-Eggitt IM, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF: Alstrom syndrome. Report of 22 cases and literature review. Ophthalmology 1998;105:1274-1280.
28. Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM: New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 2005; 165:675-683.
29. Minton JA, Owen KR, Ricketts CJ, Crabtree N, Shaikh G, Ehtisham S, Porter JR, Carey C, Hodge D, Paisey R, Walker M, Barrett TG: Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab 2006;91:3110-3116.
30. Maffei P, Munno V, Marshall JD, Scandellari C, Sicolo N: The Alstrom syndrome: is it a rare or unknown disease? Ann Ital Med Int 2002;17:221-228.
31. Alter CA, Moshang T Jr: Growth hormone deficiency in two siblings with Alstrom syndrome. Am J Dis Child 1993;147:97-99.
32. Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin M, Nishina PM, Naggert JK: Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet 2002;31:74-78.
33. Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, White C, Connolly V, Taylor JF, Russell-Eggitt I, Bonneau D, Walker M, Wilson DI: Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet 2002;31:79-83.
34. Patel S, Minton JA, Weedon MN, Frayling TM, Ricketts C, Hitman GA, McCarthy MI, Hattersley AT, Walker M, Barrett TG: Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK population. Diabetologia 2006;49:1209-1213.
35. Hart LM, Maassen JA, Dekker JM, Heine RJ: Lack of association between gene variants in the ALMS1 gene and Type 2 diabetes mellitus. Diabetologia 2003;46:1023-1024.
36. Chandler KE, Kidd A, Al Gazali L, Kolehmainen J, Lehesjoki AE, Black GC, Clayton-Smith J: Diagnostic criteria, clinical characteristics, and natural history of Cohen syndrome. J Med Genet 2003; 40:233-241.
37. Kivitie-Kallio S, Norio R: Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet 2001;102:125-135.
38. Cohen MM Jr, Hall BD, Smith DW, Graham CB, Lampert KJ: A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies. J Pediatr 1973;83:280-284.
39. Fryns JP, Legius E, Devriendt K, Meire F, Standaert L, Baten E, van den Berghe H: Cohen syndrome: the clinical symptoms and stigmata at a young age. Clin Genet 1996;49:237-241.
40. Seifert W, Holder-Espinasse M, Spranger S, Hoeltzenbein M, Rossier E, Dollfus H, Lacombe D, Verloes A, Chrzanowska KH, Maegawa GH, Chitayat D, Kotzot D, Huhle D, Meinecke P, Albrecht B, Mathijssen I, Leheup B, Raile K, Hennies HC, Horn D: Mutational spectrum of COH1 and clinical heterogeneity in Cohen syndrome. J Med Genet 2006;43:e22.
41. Norio R, Raitta C, Lindahl E: Further delineation of the Cohen syndrome; report on chorioretinal dystrophy, leukopenia and consanguinity. Clin Genet 1984;25:1-14.
42. Kivitie-Kallio S, Summanen P, Raitta C, Norio R: Ophthalmologic findings in Cohen syndrome. A long-term follow-up. Ophthalmology 2000;107:1737-1745.
43. Olivieri O, Lombardi S, Russo C, Corrocher R: Increased neutrophil adhesive capability in Cohen syndrome, an autosomal recessive disorder associated with granulocytopenia. Haematologica 1998;83: 778-782.
44. Kivitie-Kallio S, Rajantie J, Juvonen E, Norio R: Granulocytopenia in Cohen syndrome. Br J Haematol 1997;98:308-311.
45. Kolehmainen J, Black GC, Saarinen A, Chandler K, Clayton-Smith J, Traskelin AL, Perveen R, Kivitie-Kallio S, Norio R, Warburg M, Fryns JP, de la Chapelle A, Lehesjoki AE: Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet 2003;72:1359-1369.
46. Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP: Analysis of the human VPS13 gene family. Genomics 2004;84:536-549.
47. Mochida GH, Rajab A, Eyaid W, Lu A, Al Nouri D, Kosaki K, Noruzinia M, Sarda P, Ishihara J, Bodell A, Apse K, Walsh CA: Broader geographical spectrum of Cohen syndrome due to COH1 mutations. J Med Genet 2004;41:e87.
48. Temtamy SA: Carpenter's syndrome: acrocephalopolysyndactyly. An autosomal recessive syndrome. J Pediatr 1966;69:111-120.
49. Carpenter G: Case of acrocephaly with other congenital malformations. Proc Roy Soc Med 1909;2:199-201.
50. McLoughlin TG, Krovetz LJ, Schiebler GL: Heart disease in the Laurence-Moon-Biedl-Bardet syndrome: a review and a report of 3 brothers. J Pediatr 1964;65:388-399.
51. Jenkins D, Seelow D, Jehee FS, Perlyn CA, Alonso LG, Bueno DF, Donnai D, Josifiova D, Mathijssen IM, Morton JE, Orstavik KH, Sweeney E, Wall SA, Marsh JL, Nurnberg P, Passos-Bueno MR, Wilkie AO: RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet 2007;80:1162-1170.
52. Albright F, Burnett C, Smith P, Parson W: Pseudohypoparathyroidism: an example of 'Seabright-Bantam syndrome'. Endocrinol 1942;30: 922-932.
53. Weinstein LS, Yu S, Warner DR, Liu J: Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 2001;22:675-705.
54. Ong KK, Amin R, Dunger DB: Pseudohypoparathyroidism - another monogenic obesity syndrome. Clin Endocrinol (Oxf) 2000;52:389-391.
55. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ: Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995;376:348-351.
56. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H: Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001;38:792-798.
57. Prader A, Labhart A, Willi H: Ein syndrome von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonieartigem zustand im neugeborenenalter. Schweiz Med Wochenschr 1956;86:1260-1261.
58. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F: Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402.
59. Goldstone AP: Prader-Willi syndrome: advances in its genetics, pathophysiology and treatment. Trends Endocrinol Metab 2004;15:12-20.
60. Burman P, Ritzen EM, Lindgren AC: Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 2001;22:787-799.
61. Nicholls RD, Knepper JL: Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2002;2:153-175.
62. Lee S, Walker CL, Wevrick R: Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain. Gene Expr Patterns 2003;3:599-609.
63. Kuwako K, Hosokawa A, Nishimura I, Uetsuki T, Yamada M, Nada S, Okada M, Yoshikawa K: Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival. J Neurosci 2005;25:7090-7099.
64. Lee S, Walker CL, Karten B, Kuny SL, Tennese AA, O'Neill MA, Wevrick R: Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum Mol Genet 2005;14:627-637.
65. Muscatelli F, Abrous DN, Massacrier A, Boccaccio I, Le Moal M, Cau P, Cremer H: Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 2000;9:3101-3110.
66. Ren J, Lee S, Pagliardini S, Gerard M, Stewart CL, Greer JJ, Wevrick R: Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J Neurosci 2003;23:1569-1573.
67. Pagliardini S, Ren J, Wevrick R, Greer JJ: Developmental abnormalities of neuronal structure and function in prenatal mice lacking the prader-willi syndrome gene necdin. Am J Pathol 2005;167:175-191.
68. Andrieu D, Meziane H, Marly F, Angelats C, Fernandez PA, Muscatelli F: Sensory defects in Necdin deficient mice result from a loss of sensory neurons correlated within an increase of developmental programmed cell death. BMC Dev Biol 2006;6:56.
69. Kishore S, Stamm S: The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006;311:230-232.
70. Vitali P, Basyuk E, Le Meur E, Bertrand E, Muscatelli F, Cavaille J, Huttenhofer A: ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J Cell Biol 2005;169:745-753.
71. Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D: Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002;359:135-136.
72. Chai JH, Locke DP, Greally JM, Knoll JH, Ohta T, Dunai J, Yavor A, Eichler EE, Nicholls RD: Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet 2003;73:898-925.
73. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T: Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 2004;113:565-573.
74. Dudley O, Muscatelli F: Clinical evidence of intrauterine disturbance in Prader-Willi syndrome, a genetically imprinted neurodevelopmental disorder. Early Hum Dev 7 A.D.;83:471-478.
75. Stevenson DA, Heinemann J, Angulo M, Butler MG, Loker J, Rupe N, Kendell P, Clericuzio CL, Scheimann AO: Deaths due to choking in Prader-Willi syndrome. Am J Med Genet A 2007;143: 484-487.
76. Wharton R, Wang T, GraemeCook F, Briggs S, Cole R: Acute idiopathic gastric dilatation with gastric necrosis in individuals with Prader-Willi syndrome. Am J Med Genet 1997;73:437-441.
77. Eiholzer U: A comprehensive approach to limiting weight gain and to normalising body composition in Prader-Willi syndrome; in Eiholzer U, l'Allemand D, Zipf W (eds): Prader-Willi syndrome as a Model for Obesity. Basel, Karger, 2003, pp 211-221.
78. Papavramidis ST, Kotidis EV, Gamvros O: Prader-Willi syndrome-associated obesity treated by biliopancreatic diversion with duodenal switch. Case report and literature review. J Pediatr Surg 2006;41:1153-1158.
79. Goldstone AP, Brynes AE, Thomas EL, Bell JD, Frost G, Holland A, Ghatei MA, Bloom SR: Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr 2002;75:468-475.
80. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A, Bloom SR: Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 2001;86:4330-4338.
81. Goldstone AP, Unmehopa UA, Thomas EL et al: Hypothalamic neuropeptides and regulation of fat mass in Prader-Willi syndrome; in Eiholzer U, l'Allemand D, Zipf W (eds): Prader-Willi Syndrome as a Model for Obesity. Basel, Karger, 2003, pp 31-43.
82. Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, Grossman AB, Korbonits M: Fasting and post-prandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY 3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab 2005;90:2681-2690.
83. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG: Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes (Lond) 2006;30:382-387.
84. Allen DB, Carrel AL: Growth hormone therapy for Prader-Willi syndrome: a critical appraisal. J Pediatr Endocrinol Metab 2004;17(suppl 4):1297-1306.
85. Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB: Two years of growth hormone therapy in young children with Prader-Willi syndrome: Physical and neurodevelopmental benefits. Am J Med Genet 2007;143:443-448.
86. Holland AJ, Treasure J, Coskeran P, Dallow J, Milton N, Hillhouse E: Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome. Int J Obes 1993;17:527-532.
87. Choe YH, Jin DK, Kim SE, Song SY, Paik KH, Park HY, Oh YJ, Kim AH, Kim JS, Kim CW, Chu SH, Kwon EK, Lee KH: Hyperghrelinemia does not accelerate gastric emptying in Prader-Willi syndrome patients. J Clin Endocrinol Metab 2005;90: 3367-3370.
88. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS: Elevated plasma ghrelin levels in Praderh Willi syndrome. Nat Med 2002;8:643-644.
89. Choe YH, Song SY, Paik KH, Oh YJ, Chu SH, Yeo SH, Kwon EK, Kim EM, Rha MY, Jin DK: Increased density of ghrelin expressing cells in the gastric fundus and body in Prader-Willi syndrome. J Clin Endocrinol Metab 2005;90:5441-5445.
90. Tan TM, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP: Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 2004;89:4162-4165.
91. Zipf WB, O'Dorisio TM, Cataland S, Dixon K: Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome. J Clin Endocrinol Metab 1983;57:1074-1080.
92. Goldstone AP: The hypothalamus, hormones, and hunger: alterations in human obesity and illness. Prog Brain Res 2006;153:57-73.
93. Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, Chance RE: Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 1993;14:497-503.
94. Goldstone AP, Unmehopa UA, Bloom SR, Swaab DF: Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J Clin Endocrinol Metab 2002;87:927-937.
95. Goldstone AP, Unmehopa UA, Swaab DF: Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity (erratum in Clin Endocrinol 59, 266, 2003). Clin Endocrinol (Oxf) 2003;58:743-755.
96. Fronczek R, Lammers GJ, Balesar R, Unmehopa UA, Swaab DF: The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi Syndrome. J Clin Endocrinol Metab 2005;90: 5466-5470.
97. Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E, Nishino S: Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol 2005;12:70-72.
98. Swaab DF, Purba JS, Hofman MA: Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 1995;80:573-579.
99. Gabreëls BATF, Swaab DF, deKleijn DPV, Seidah NG, Van de Loo JW, Van de Ven WJM, Martens GJM, van Leeuwen FW: Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: Indications for a processing defect. J Clin Endocrinol Metab 1998;83:591-599.
100. Swaab DF: Prader-Willi syndrome and the hypothalamus. Acta Paediatr Suppl 1997;423:50-54.
101. Miller J, Kranzler J, Liu Y, Schmalfuss I, Theriaque DW, Shuster JJ, Hatfield A, Mueller OT, Goldstone AP, Sahoo T, Beaudet AL, Driscoll DJ: Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J Pediatr 2006;149:192-198.
102. Leonard CM, Williams CA, Nicholls RD, Agee OF, Voeller KK, Honeyman JC, Staab EV: Angelman and Prader-Willi syndrome: a magnetic resonance imaging study of differences in cerebral structure. Am J Med Genet 1993;46:26-33.
103. Yamada K, Matsuzawa H, Uchiyama M, Kwee IL, Nakada T: Brain developmental abnormalities in Prader-Willi syndrome detected by diffusion tensor imaging. Pediatrics 2006;118:E442-E448.
104. Miller JL, Couch JA, Schmalfuss I, He G, Liu Y, Driscoll DJ: Intracranial abnormalities detected by three-dimensional magnetic resonance imaging in Prader-Willi syndrome. Am J Med Genet A 2007;143:476-483.
105. Miller JL, Goldstone AP, Couch JA, Shuster J, He G, Driscoll DJ, Liu Y, Schmalfuss IM: Pituitary abnormalities in Prader-Willi syndrome and early-onset morbid obesity. Am J Med Genet 2007, Part A, in press.
106. Shapira NA, Lessig MC, He GA, James GA, Driscoll DJ, Liu Y: Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI. J Neurol Neurosurg Psych 2005;76:260-262.
107. Hinton EC, Holland AJ, Gellatly MS, Soni S, Patterson M, Ghatei MA, Owen AM: Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obes 2005;30:313-321.
108. Holsen LM, Zarcone JR, Brooks WM, Butler MG, Thompson TI, Ahluwalia JS, Nollen NL, Savage CR: Neural mechanisms underlying hyperphagia in Prader-Willi Syndrome. Obesity 2006;14: 1028-1037.
109. Miller JL, James GA, Goldstone AP, Couch JA, He G, Driscoll DJ, Liu Y: Enhanced activation of reward-mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome. J Neurol Neurosurg Psychiatry 2007;78:615-619.
110. Maina EN, Webb T, Soni S, Whittington J, Boer H, Clarke D, Holland A: Analysis of candidate imprinted genes in PWS subjects with atypical genetics: a possible inactivating mutation in the SNURF/SNRPN minimal promoter. J Hum Genet 2007;52:297-307.
111. Oeffner F, Korn T, Roth H, Ziegler A, Hinney A, Goldschmidt H, Siegfried W, Hebebrand J, Grzeschik KH: Systematic screening for mutations in the human necdin gene (NDN): identification of two naturally occurring polymorphisms and association analysis in body weight regulation. Int J Obes Relat Metab Disord 2001;25:767-769.
112. O'Neill MA, Farooqi IS, Wevrick R: Evaluation of Prader-Willi Syndrome gene MAGEL2 in severe childhood-onset obesity. Obes Res 2005;13:1841-1842.
113. Meyre D, Lecoeur C, Delplanque J, Francke S, Vatin V, Durand E, Weill J, Dina C, Froguel P: A genomewide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-q23.2. Diabetes 2004;53:803-811.
114. Feitosa MF, Borecki IB, Rich SS, Arnett DK, Sholinsky P, Myers RH, Leppert M, Province MA: Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 2002;70:72-82.
115. Varela MC, Simoes-Sato AY, Kim CA, Bertola DR, de Castro CI, Koiffmann CP: A new case of interstitial 6q16.2 deletion in a patient with Prader-Willi-like phenotype and investigation of SIM1 gene deletion in 87 patients with syndromic obesity. Eur J Med Genet 2006;49:298-305.
116. Holder JLJ, Butte NF, Zinn AR: Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet 2000;9:101-108.
117. Michaud JL, Boucher F, Melnyk A, Gauthier F, Goshu E, Levy E, Mitchell GA, Himms-Hagen J, Fan CM: Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet 2001;10:1465-1473.
118. Holder Jr JL, Zhang L, Kublaoui BM, DiLeone RJ, Oz OK, Bair CH, Lee YH, Zinn AR: Sim1 gene dosage modulates the homeostatic feeding response to increased dietary fat in mice. Am J Physiol Endocrinol Metab 2004;287:E105-E113.
119. Kublaoui BM, Holder JL Jr, Tolson KP, Gemelli T, Zinn AR: SIM1 overexpression partially rescues agouti yellow and diet-induced obesity by normalizing food intake. Endocrinol 2006;147:4542-4549.
120. Kublaoui BM, Holder JL Jr, Gemelli T, Zinn AR: Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol Endocrinol 2006;20: 2483-2492.
121. D'Angelo CS, Da Paz JA, Kim CA, Bertola DR, Castro CI, Varela MC, Koiffmann CP: Prader-Willi-like phenotype: investigation of 1p36 deletion in 41 patients with delayed psychomotor development, hypotonia, obesity and/or hyperphagia, learning disabilities and behavioral problems. Eur J Med Genet 2006;49:451-460.
122. Phelan MC, Rogers RC, Clarkson KB, Bowyer FP, Levine MA, Estabrooks LL, Severson MC, Dobyns WB: Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals. Am J Med Genet 1995;58:1-7.
123. Wilson LC, Leverton K, Oude Luttikhuis ME, Oley CA, Flint J, Wolstenholme J, Duckett DP, Barrow MA, Leonard JV, Read AP: Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet 1995;56:400-407.
124. Shrimpton AE, Braddock BR, Thomson LL, Stein CK, Hoo JJ: Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype. Clin Genet 2004;66:537-544.
125. Polityko A, Maltseva O, Rumyantseva N, Khurs O, Seidel J, Claussen U, Weise A, Liehr T, Starke H: Two further AHO-like syndrome patients with deletion of glypican 1 gene region in 2q37.2-q37.3. Int J Mol Med 2004;14:977-979.
126. Cormier-Daire V, Molinari F, Rio M, Raoul O, De Blois MC, Romana S, Vekemans M, Munnich A, Colleaux L: Cryptic terminal deletion of chromosome 9q34: a novel cause of syndromic obesity in childhood? J Med Genet 2003;40:300-303.
127. Neas KR, Smith JM, Chia N, Huseyin S, St Heaps L, Peters G, Sholler G, Tzioumi D, Sillence DO, Mowat D: Three patients with terminal deletions within the subtelomeric region of chromosome 9q. Am J Med Genet A 2005;132:425-430.
128. Harada N, Visser R, Dawson A, Fukamachi M, Iwakoshi M, Okamoto N, Kishino T, Niikawa N, Matsumoto N: A 1-Mb critical region in six patients with 9q34.3 terminal deletion syndrome. J Hum Genet 2004;49:440-444.
129. Cotter PD, Kaffe S, McCurdy LD, Jhaveri M, Willner JP, Hirschhorn K: Paternal uniparental disomy for chromosome 14: a case report and review. Am J Med Genet 1997;70:74-79.
130. Kurosawa K, Sasaki H, Sato Y, Yamanaka M, Shimizu M, Ito Y, Okuyama T, Matsuo M, Imaizumi K, Kuroki Y, Nishimura G: Paternal UPD14 is responsible for a distinctive malformation complex. Am J Med Genet 2002;110:268-272.
131. Mitter D, Buiting K, von Eggeling F, Kuechler A, Liehr T, Mau-Holzmann UA, Prott EC, Wieczorek D, Gillessen-Kaesbach G: Is there a higher incidence of maternal uniparental disomy 14 [upd(14) mat]? Detection of 10 new patients by methylation-specific PCR. Am J Med Genet A 2006;140: 2039-2049.
132. Fryns JP, Haspeslagh M, Dereymaeker AM, Volcke P, van den BH: A peculiar subphenotype in the fra(X) syndrome: extreme obesity-short stature-stubby hands and feet-diffuse hyperpigmentation. Further evidence of disturbed hypothalamic function in the fra(X) syndrome? Clin Genet 1987;32: 388-392.
133. de Vries BB, Fryns JP, Butler MG, Canziani F, Wesby-van Swaay E, van Hemel JO, Oostra BA, Halley DJ, Niermeijer MF: C linical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet 1993;30:761-766.
134. Borjeson M, Forssman H, Lehmann O: An X-linked, recessively inherited syndrome characterized by grave mental deficiency, epilepsy, and endocrine disorder. Acta Med Scand 1962;171: 13-21.
135. Birrell G, Lampe A, Richmond S, Bruce SN, Gecz J, Lower K, Wright M, Cheetham TD: Borjeson-Forssman-Lehmann syndrome and multiple pituitary hormone deficiency. J Pediatr Endocrinol Metab 2003;16:1295-1300.
136. Lower KM, Turner G, Kerr BA, Mathews KD, Shaw MA, Gedeon AK, Schelley S, Hoyme HE, White SM, Delatycki MB, Lampe AK, Clayton-Smith J, Stewart H, van Ravenswaay CM, de Vries BB, Cox B, Grompe M, Ross S, Thomas P, Mulley JC, Gecz J: Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet 2002;32:661-665.
137. Gecz J, Turner G, Nelson J, Partington M: The Borjeson-Forssman-Lehman syndrome (BFLS, MIM #301900). Eur J Hum Genet 2006;14: 1233-1237.
138. Crawford J, Lower KM, Hennekam RC, Van Esch H, Megarbane A, Lynch SA, Turner G, Gecz J: Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient. J Med Genet 2006;43:238-243.
139. Moretti-Ferreira D, Koiffmann CP, Listik M, Setian N, Wajntal A: Macrosomia, obesity, macrocephaly and ocular abnormalities (MOMO syndrome) in two unrelated patients: delineation of a newly recognized overgrowth syndrome. Am J Med Genet 1993;46:555-558.
140. Zannolli R, Mostardini R, Hadjistilianou T, Rosi A, Berardi R, Morgese G: MOMO syndrome: a possible third case. Clin Dysmorphol 2000;9:281-284.
141. Davenport JR, Watts AJ, Roper VC, Croyle MJ, van Groen T, Wyss JM, Nagy TR, Kesterson RA, Yoder BK: Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr Biol 2007;17:1586-1594.
142. Krepischi-Santos AC, Vianna-Morgante AM, Jehee FS, Passos-Bueno MR, Knijnenburg J, Szuhai K, Sloos W, Mazzeu JF, Kok F, Cheroki C, Otto PA, Mingroni-Netto RC, Varela M, Koiffmann C, Kim CA, Bertola DR, Pearson PL, Rosenberg C: Whole-genome array-CGH screening in undiagnosed syndromic patients: old syndromes revisited and new alterations. Cytogenet Genome Res 2006;115:254-261.
143. Zung A, Rienstein S, Rosensaft J, Aviram-Goldring A, Zadik Z: Proximal 19q trisomy: a new syndrome of morbid obesity and mental retardation. Horm Res 2006;67:105-110.